Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
CAMBRIDGE, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 2026 Jefferies Global Healthcare Conference in London being held on November 16-19, 2026. Dr. Aiyar’s presentation will take place on Thursday, November 19 th at 8:00 AM GMT (3:00 AM ET).